Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Current Leases (2021 - 2023)

Rapid Therapeutic Science Laboratories' Current Leases history spans 3 years, with the latest figure at $100650.0 for Q2 2023.

  • For Q2 2023, Current Leases rose 30.2% year-over-year to $100650.0; the TTM value through Jun 2023 reached $100650.0, up 30.2%, while the annual FY2022 figure was $98509.0, 34.41% up from the prior year.
  • Current Leases for Q2 2023 was $100650.0 at Rapid Therapeutic Science Laboratories, up from $99580.0 in the prior quarter.
  • Across five years, Current Leases topped out at $100650.0 in Q2 2023 and bottomed at $73289.0 in Q4 2021.
  • The 3-year median for Current Leases is $79350.0 (2022), against an average of $86280.9.
  • The largest annual shift saw Current Leases soared 34.41% in 2022 before it skyrocketed 30.2% in 2023.
  • A 3-year view of Current Leases shows it stood at $73289.0 in 2021, then surged by 34.41% to $98509.0 in 2022, then grew by 2.17% to $100650.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Current Leases are $100650.0 (Q2 2023), $99580.0 (Q1 2023), and $98509.0 (Q4 2022).